fda warning letters glp-1 october 2025 π¨ Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of medications like semaglutide and tirzepatide, signaling a major shift in how these September 15, 2025: Telehealth company
Description
Data Synthesis Twenty-two reports and six prescribing sheets were included

GLP-1 drugs could rapidly evolve beyond current use as diabetes and weight loss medications, with new research pointing to potential benefits in cancer, ageing, addiction, osteoarthritis and heart health

Read Important Safety and Prescribing Information, including Boxed Warning.

It is typically used alongside a healthy diet and exercise program to help manage diabetes

Then feel stronger, more in control, and more consistent over 34 months of daily use.* SUPPORT APPETITE, ENERGY, AND MOTIVATION NATURALLY: Feel fuller longer without feeling forced

functional benefits)
